Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: Nivolumab or brentuximab vedotin with the AVD regimen.
作者信息
Okeleji Olayinka, Gibson Amber, Nunez Cesar, Garcia Miriam B, Roth Michael, Cuglievan Branko, McCall David
机构信息
Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
出版信息
Pediatr Blood Cancer. 2024 Aug;71(8):e31091. doi: 10.1002/pbc.31091. Epub 2024 Jun 5.
PMID:38840433
Abstract
摘要
Zotero 插件